Neurology Update: Rare Diseases
Jes Olensen, clinical professor in the department of clinical neurology, Rigshospitalet, Denmark, has been awarded the Brain Prize along with Michael Moskowitz, Lars Edvinsson and Peter Goadsby for discovering a key mechanism that causes migraine which has since led to revolutionary new treatments.
Latest Posts
-
-
Jes Olensen, clinical professor in the department of clinical neurology, Rigshospitalet, Denmark, has been awarded the Brain Prize along with Michael Moskowitz, Lars Edvinsson and Peter Goadsby for discovering a key mechanism that causes migraine which has since led to revolutionary new treatments.
-
FLAG-ERA gathers National and Regional Funding Organisations (NRFOs) in Europe and beyond with the goal of supporting, together with the European Commission, the FET Flagship initiatives, i.e., the Graphene Flagship and the Human Brain Project (HBP) Flagship. -
COVID-19General interestInterviewsCOVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde)
COVID-19 around the World: Clinician interviews on experience and impact of the virus (Cape Verde) -
News from EAN member societiesMiscellaneaNews from EMA: First oral treatment for spinal muscular atrophy (SMA) recommended for approval
News from EMA: First oral treatment for spinal muscular atrophy (SMA) recommended for approval -
General interestAcademic/ScientificMiscellaneaBrain Talks: Professor Günther Deuschl addresses burden of neurological diseases in Europe
Brain Talks: Professor Günther Deuschl addresses burden of neurological diseases in Europe -
COVID-19Academic/ScientificBreaking newsSerum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms
Serum and CSF alpha-synuclein levels do not change in COVID-19 patients with neurological symptoms -
COVID-19 continuous-EEG case series: A Descriptive Study -
COVID-19Academic/ScientificBreaking news
Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients
Acute ischemic stroke and COVID-19: An analysis of 27 676 Patients -
COVID-19Academic/ScientificBreaking news
Inflammatory cytokine patterns associated with neurological diseases in COVID-19
Inflammatory cytokine patterns associated with neurological diseases in COVID-19 -
COVID-19Academic/ScientificBreaking newsSusceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection
Susceptibility of neuroblastoma and glioblastoma cell lines to SARS-CoV-2 infection -
COVID-19Academic/ScientificBreaking news
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6
Latent class cluster analysis identified hidden headache phenotypes in COVID-19: impact of pulmonary infiltration and IL-6 -
COVID-19Academic/ScientificBreaking news
Neurological manifestations as primary presentation of COVID-19 in hospitalized patients
Neurological manifestations as primary presentation of COVID-19 in hospitalized patients -
COVID-19Academic/ScientificBreaking newsCerebrospinal fluid in COVID-19: A systematic review of the literature
Cerebrospinal fluid in COVID-19: A systematic review of the literature -
COVID-19Academic/ScientificBreaking news
Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis
Impact of coronavirus disease 2019 in a French cohort of myasthenia gravis
Newer Posts